Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![doepke_michel Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1350720698591936515.png) Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4843 followers
Created: 2025-07-14 12:02:34 UTC

$CORT Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer. $ABBV

![](https://pbs.twimg.com/card_img/1944729229540687872/iC4JH-Ho?format=jpg&name=800x419)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944729228684976503/c:line.svg)

**Related Topics**
[abbv](/topic/abbv)
[cort](/topic/cort)
[$cort](/topic/$cort)
[$abbv](/topic/$abbv)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/doepke_michel/status/1944729228684976503)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

doepke_michel Avatar Michel Doepke @doepke_michel on x 4843 followers Created: 2025-07-14 12:02:34 UTC

$CORT Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer. $ABBV

XXXXX engagements

Engagements Line Chart

Related Topics abbv cort $cort $abbv stocks healthcare

Post Link

post/tweet::1944729228684976503
/post/tweet::1944729228684976503